AVERA MCKENNAN HOSPITAL & UNIVERSITY HEALTH CENTER (Sioux Falls, SD) prices

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
Q2056	Citacabtagene Autoleucel 70 Ml	$2,403,816	$2,163,435	—	—	0
Q2056	Citacabtagene Autoleucel 70 Ml	$2,403,816	$2,163,435	—	—	7
Q2054	Lisocabtagene Maraleucel	$2,325,566	$2,093,010	—	—	0
Q2054	Lisocabtagene Maraleucel	$2,325,566	$2,093,010	—	—	9
819	Bone Marrow Acquisition Donor	$277,470	$249,723	—	—	5
A9513	Radiopharm Lutetium Dot 200mci	$271,877	$244,689	—	—	0
A9513	Radiopharm Lutetium Dot 200mci	$271,877	$244,689	—	—	7
A9607	Radiopharm Plucivto 200 mci	$215,071	$193,564	—	—	0
A9607	Radiopharm Plucivto 200 mci	$215,071	$193,564	—	—	11
J1823	Inebilizumab-Cdon 100 Mg/10 Ml	$205,692	$185,124	—	—	0
J1823	Inebilizumab-Cdon 100 Mg/10 Ml	$205,692	$185,124	—	—	9
J2351	Ocrelizumab-Hyaluronidase-Ocsq	$186,049	$167,445	—	—	0
J2351	Ocrelizumab-Hyaluronidase-Ocsq	$186,049	$167,445	—	—	11
J9347	Tremelimumab-Actl 300 Mg/15 Ml	$179,345	$161,411	—	—	0
J9347	Tremelimumab-Actl 300 Mg/15 Ml	$179,345	$161,411	—	—	10
812	Kidney Acquisition	$159,563	$143,607	—	—	5
811	Kidney Acquisition Live Donor	$159,563	$143,607	—	—	5
J9269	Tagraxofusp-Erzs 1,000 Mcg/Ml	$144,971	$130,474	—	—	0
J9269	Tagraxofusp-Erzs 1,000 Mcg/Ml	$144,971	$130,474	—	—	9
J2507	Pegloticase 8 Mg/Ml Sdv	$128,992	$116,093	—	—	0
J2507	Pegloticase 8 Mg/Ml Sdv	$128,992	$116,093	—	—	9
J9359	Loncastuximab Tesirine-Lpyl	$120,277	$108,250	—	—	0
J9359	Loncastuximab Tesirine-Lpyl	$120,277	$108,250	—	—	11
J9266	Pegaspargase 3750 Unit/5 ML	$115,222	$103,700	—	—	0
J9266	Pegaspargase 3750 Unit/5 ML	$115,222	$103,700	—	—	12
J9229	Inotuzumab Ozogamicin 0.9 Mg	$101,810	$91,630	—	—	0
J9229	Inotuzumab Ozogamicin 0.9 Mg	$101,810	$91,630	—	—	10
C1831	Kit Nvg Aprevo Lvl 1	$96,200	$86,580	—	—	0
C1831	Kit Nvg Aprevo Lvl 1	$96,200	$86,580	—	—	6
J2350	Ocrelizumab 300 Mg/10 Ml	$89,167	$80,251	—	—	0
J2350	Ocrelizumab 300 Mg/10 Ml	$89,167	$80,251	—	—	14
J9309	Polatuzumab Ved-Piiq 140 Mg Vl	$82,388	$74,150	—	—	0
J9309	Polatuzumab Ved-Piiq 140 Mg Vl	$82,388	$74,150	—	—	13
J3316	Triptorelin 22.5 Mg Vial	$82,008	$73,808	—	—	0
J3316	Triptorelin 22.5 Mg Vial	$82,008	$73,808	—	—	9
J0638	Canakinumab Inj 150Mg/Ml Vial	$80,319	$72,288	—	—	0
J0638	Canakinumab Inj 150Mg/Ml Vial	$80,319	$72,288	—	—	11
J3241	Teprotumumab-Trbw 500 Mg Vial	$73,769	$66,392	—	—	0
J3241	Teprotumumab-Trbw 500 Mg Vial	$73,769	$66,392	—	—	9
J9334	Efgart-Hyalu-QVFC 1008Mg/5.6Ml	$71,128	$64,016	—	—	0
J9334	Efgart-Hyalu-QVFC 1008Mg/5.6Ml	$71,128	$64,016	—	—	9
J1628	Guselkumab 200 Mg/20 Ml Vial	$68,626	$61,764	—	—	0
J1628	Guselkumab 200 Mg/20 Ml Vial	$68,626	$61,764	—	—	9
J9298	Nivolum/Relatlim 240-80Mg 113G	$66,580	$59,922	—	—	0
J9298	Nivolum/Relatlim 240-80Mg 113G	$66,580	$59,922	—	—	11
36906	PTA Periph Dial Seg W Stent	$65,011	$58,510	—	—	0
36906	PTA Periph Dial Seg W Stent	$65,011	$58,510	—	—	9
J9043	Cabazitaxel 60 MG/1.5 ML Vial	$63,959	$57,563	—	—	0
J9043	Cabazitaxel 60 MG/1.5 ML Vial	$63,959	$57,563	—	—	10
C9606	Acute MI DES PCI	$60,214	$54,193	—	—	0

Showing top 50 of 8,492 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.